The disclosure provides compounds of Formula (I), deuterated derivatives of those compounds, and pharmaceutically acceptable salts of those compounds and derivatives, compositions comprising the same, and methods of using the same, including use in treating APOL1 mediated kidney disease.
该披露提供了式(I)的化合物,这些化合物的
氘代衍
生物,以及这些化合物和衍
生物的药用盐,包含这些化合物的组合物,以及使用这些化合物的方法,包括用于治疗APOL1介导的肾病。